Siehe auch...
NG2 Antikörper
Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|---|
NG2 Antikörper (LHM 2) | sc-53389 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 22 | ||
NG2 Antikörper (132.38) | sc-33666 | mouse IgG1 κ | 1592-2222 (h) | WB, IP, IF, IHC(P) | m, r | 8 | ||
NG2 Antikörper (G-9) | sc-166251 | mouse IgG2a κ | 2023-2322 (h) | WB, IP, IF, ELISA | m, r, h | 11 | ||
NG2 Antikörper (5H26) | sc-71690 | mouse IgG1 κ | 1592-2222 (h) | WB, IP, IF | m, r | neu | ||
NG2 Antikörper (F-12) | sc-166179 | mouse IgG2a κ | 2023-2322 (h) | WB, IP, IF, ELISA | h | neu | ||
NG2 Antikörper (9.2.27) | sc-80003 | mouse IgG2a κ | (h) | IP, IF, FCM | h | 3 | ||
NG2 Antikörper (7.1) | sc-53508 | mouse IgG1 κ | FL (h) | WB, IP, IF, FCM | h | 1 | ||
NG2 Antikörper (4D1) | sc-47718 | mouse IgM κ | (bovine) | WB, IP, IF, IHC(P) | m, r, h | 2 |
NG2 CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
NG2 CRISPR/Cas9 KO Plasmid (h) | sc-400699 | h | Gene Knockout | GFP | 0 | ||
NG2 HDR Plasmid (h) | sc-400699-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
NG2 Double Nickase Plasmid (h) | sc-400699-NIC | h | Gene Knockout | Puromycin | 0 | ||
NG2 Double Nickase Plasmid (h2) | sc-400699-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
NG2 CRISPR/Cas9 KO Plasmid (m) | sc-431202 | m | Gene Knockout | GFP | 0 | ||
NG2 HDR Plasmid (m) | sc-431202-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
NG2 Double Nickase Plasmid (m) | sc-431202-NIC | m | Gene Knockout | Puromycin | 0 | ||
NG2 Double Nickase Plasmid (m2) | sc-431202-NIC-2 | m | Gene Knockout | Puromycin | 0 |
NG2 CRISPR Activation Products
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
NG2 CRISPR Activation Plasmid (h) | sc-400699-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NG2 CRISPR Activation Plasmid (h2) | sc-400699-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NG2 Lentiviral Activation Particles (h) | sc-400699-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NG2 Lentiviral Activation Particles (h2) | sc-400699-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
NG2 CRISPR Activation Plasmid (m) | sc-431202-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NG2 CRISPR Activation Plasmid (m2) | sc-431202-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NG2 Lentiviral Activation Particles (m) | sc-431202-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
NG2 Lentiviral Activation Particles (m2) | sc-431202-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
NG2 siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
NG2 siRNA (h) | sc-40771 | h | Gene Silencing | N/A | 4 | ||
NG2 shRNA Plasmid (h) | sc-40771-SH | h | Gene Silencing | Puromycin | 4 | ||
NG2 shRNA (h) Lentivirale Partikel | sc-40771-V | h | Gene Silencing | Puromycin | 4 | ||
NG2 siRNA (m) | sc-40772 | m | Gene Silencing | N/A | 0 | ||
NG2 shRNA Plasmid (m) | sc-40772-SH | m | Gene Silencing | Puromycin | 0 | ||
NG2 shRNA (m) Lentivirale Partikel | sc-40772-V | m | Gene Silencing | Puromycin | 0 |